2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Amedisys (AMED) PT Raised to $60 at Baird Following 3Q
November 10, 2017 8:56 AM ESTBaird raised its price target on Amedisys (NASDAQ: AMED) to $60.00 (from $50.00) while maintaining a Neutral rating following the company's 3Q release. 3Q17 revenues of $386.7m beat consensus of $385.3m by 0.4%. EBITDA of $36.9m beat consensus of $35.5m by 3.9% and EPS of $0.56 exceeded consensus at $0.53... More
